Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Completion of investment by Life Biosciences LLC and capital raising update

April 8, 2019 Kerry Rowe

Completion of investment by Life Biosciences LLC and capital raising update

Post navigation

Results of General Meeting

Change of Company Name

Related Posts

Annual Report Filed on Form 20-F with SEC

September 7, 2017

Video Interview: Professor Ira Shoulson

May 14, 2014

Prana Maintains NASDAQ Listing

April 11, 2016

Recent Posts

XBRL 30 June 2020 filed with the SEC
New data independently confirms and extends laboratory findings and expands safety profile of ATH434
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
Alterity receives a $4.8 million R&D Tax Incentive Refund

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065